Nouvelle déclaration d'incident
No de la demande: 2013-3047
Numéro de référence du titulaire d'homologation: 2013AM117
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer Inc
Adresse: 77 Belfield Rd
Ville: Toronto
État: ON
Pays: Canada
Code postal /Zip: M9W 1G6
Incident chez un animal domestique
Pays: UNITED STATES
État: UNKNOWN
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 11556-144
Nom du produit: K9 Advantix II Large dog
Liquide
Oui
Unités: mL
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Dog / Chien
French Bulldog
1
Homme
6
33
lbs
Cutanée
>8 hrs <= 24 hrs / >8 h <= 24 h
>8 hrs <=24 hrs / > 8 h < = 24 h
Système
Unknown / Inconnu
Oui
Oui
24
Hour(s) / Heure(s)
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 07-Jan-2013, the patient began vomiting, having diarrhea, was weak, had dilated pupils, and was circling. On 08-Jan-2013, the owner bathed the patient with a baby shampoo. The dog was taken to the veterinary clinic where they performed an examination and administered atropine sulfate. Follow up of 21-Jan-2013: The dog was hospitalized overnight and IV fluids (unspecified) was given. On 09 Jan 2013 the owner declined treatments and diagnostics suggested by the DVM due to financial concerns and the dog was taken home by the owner. On the same day the dog had seizures and died of unknown causes. No necropsy was performed.
Mort
Digestive tract disorders rather unspecific in dogs and may have multiple various other causes, and not expected following topical application of product. Potential oral ingestion not reported. Although sign rather unspecific, lethargy may exceptionally occur in particular sensitive dogs or may be consequence of digestive tract disorders. Even though more expected after oral ingestion, Permethrin has potential to cause slight neurological disorders (e.g. ataxia) in particular susceptible animals. Dilated pupils not expected following appropriate product application. Known that none of active ingredients in product has potential to provoke seizures in dogs, neither alone nor in combination. Seizures reported by owner and no vet consulted. Thus possibly misinterpretation of sign. Death not expected in dog after product application, as inconsistent with pharmacotoxicological product profile. Low level of information (necropsy not available). Considering breed of dog, other etiologies more probable. No signs of allergy/anaphylactic reaction reported. Onset time of digestive disorders, lethargy, dilated pupils, and circling consistent, time to onset of seizure and death long. Considering all aspects, product connection deemed to be unlikely.